Posaconazole for Pulmonary Fungal Infection Prophylaxis in Hematopoietic Stem Cell Transplantation Patients

Inclusion Criteria: * Age ≥ 13 years old * The primary causes of hematopoietic stem cell transplantation include aplastic anemia, acute myeloid leukemia, acute lymphoblastic leukemia, non-Hodgkin's lymphoma, or other hematologic diseases in patients pretreated for hematopoietic stem cell transplantation. The types of transplantation include autologous transplantation, syngeneic transplantation, matched sibling donor transplantation, unrelated donor transplantation and haploidentical transplantation * The patients themselves or their authorized clients agree to participate in the clinical study and sign the informed consent Exclusion Criteria: * Those with evidence of active fungal infection within 3 weeks prior to enrollment * Allergic to azole drugs * Severe abnormal liver function * Rifampicin, isoniazid, phenytoin, carbamazepine, and long-acting barbiturates were used in combination during the study * Any predictably increased patient risk or other factors that might interfere with the outcome of a clinical trial